Celestra Inc
352770
Company Profile
Business description
Celestra Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology. It offers a genome-based, early cancer diagnostic service through technology for multi-omics analysis and simultaneous detection of CTC and cfDNA in the blood based.
Contact
Building 110, UNIST, 50
Suite 301-3, UNIST-gil, Eonyang-eup, Ulju-gun
Ulsan44919
KORT: +82 7082866966
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
78
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,793.10 | 120.80 | -1.53% |
| CAC 40 | 7,126.02 | 263.00 | 3.83% |
| DAX 40 | 20,562.73 | 891.85 | 4.53% |
| Dow JONES (US) | 39,577.49 | 1,030.96 | -2.54% |
| FTSE 100 | 7,913.25 | 233.77 | 3.04% |
| HKSE | 20,552.36 | 129.42 | -0.63% |
| NASDAQ | 16,421.05 | 703.92 | -4.11% |
| Nikkei 225 | 33,066.95 | 1,542.05 | -4.46% |
| NZX 50 Index | 12,020.25 | 181.18 | -1.48% |
| S&P 500 | 5,276.03 | 180.87 | -3.31% |
| S&P/ASX 200 | 7,586.50 | 123.10 | -1.60% |
| SSE Composite Index | 3,229.17 | 5.54 | 0.17% |